CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$7.92
+0.00 (+0.00%)
Open$8.03
Previous Close$7.92
Day High$8.15
Day Low$7.82
52W High$17.43
52W Low$6.13
Volume—
Avg Volume995.1K
Market Cap621.15M
P/E Ratio3.81
EPS$1.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+562.9% upside
Current
$7.92
$7.92
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 301.37M | 151.82M | 142.81M |
| Net Income | 157.65M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 139.53M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |